Ats Corporation · TSX:ATS
Ats — Q4 2024 Earnings Presentation
14 slides from Ats's earnings presentation, May 16, 2024
Slide 1: Q4 2024 Earnings Call
Q4 2024 Earnings Call May 16, 2024 8:30am ET
Slide 2: Today's Hosts
Today's Hosts Andrew Hider Ryan McLeod Chief Executive Officer Chief Financial Officer Note to Reader: This presentation and the oral statements made during this call contain certain statements that may constitute forward-looking information and forward-looking statements within the meaning of appli
Slide 3: Non-IFRS and Other Financial Measures
Non-IFRS and Other Financial Measures Throughout this presentation management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company. The terms “EBITDA”, “organic revenue”, “adjusted net income”, “adjusted earnings fr
Slide 4: Q4 2024 & Recent Highlights
Q4 2024 & Recent Highlights Record revenues and third strongest bookings1 quarter ▪ Q4 Order Bookings¹ up ~7% y/y to $791MM ▪ Q4 Revenues up ~8% y/y to $791.5MM ▪ Q4 Adj. Earnings from Operations¹ down ~6% y/y to $95.9 million, 12.1% adjusted earnings from operations margin¹ down 183 bps y/y ▪ Order
Slide 5: Outlook
Outlook Order Backlog1 provides a solid foundation to execute on our strategy • Life Sciences $871MM: funnel remains strong, supported by market growth in key areas • Transportation $425MM: funnel and outlook reflects short-term market uncertainty; longer-term fundamentals intact • Food and Beverage
Slide 6: Financial Results
Financial Results Y/Y Y/Y Y/Y Y/Y (C$ mm, except per share Q4 Q4 Change Change F2024 F2023 Change Change data) F2024 F2023 ($) (%) ($) (%) Revenues $791.5 $730.8 $60.7 8.3% $3,032.9 $2,577.4 $455.5 17.7% Revenue Growth: Y/Y Q4 Annual Earnings from operations 74.8 51.9 22.9 44.1% 315.4 222.5 92.9 41.
Slide 7: Summary
Summary ▪ Record revenues, diversified Order Bookings1, and earnings in line with expectations ▪ Estimated Q1-F25 Order Backlog-to-revenue conversion 36% to 40% ▪ Long-term outlook in strategic end-markets remains positive ▪ IT.ACA. acquisition completed in Q4 fiscal 2024; Paxiom expected to be comp
Slide 8: ATS
ATS
Slide 9: WATS
WATS
Slide 10: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix Reconciliation of Non-IFRS Measures to IFRS Measures 10
Slide 11: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted EBITDA and EBITDA to the most directly The following table reconciles organic revenue to the most directly comparable IFRS comparable IFRS measure (net income) (in millions of dollars): measure (re
Slide 12: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles adjusted earnings from operations to the most The following table reconciles adjusted basic earnings per share to the most directly comparable IFRS measures (net income) (in millions of dollars): directly c
Slide 13: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles net debt to adjusted EBITDA to the most directly The following table reconciles free cash flow to the most directly comparable comparable IFRS measure (in millions of dollars): IFRS measure (in millions of
Slide 14: Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures
Appendix: Reconciliation of Non-IFRS Measures to IFRS Measures The following table reconciles the previously reported non-IFRS financial measures to reflect the exclusion of the stock-based compensation revaluation expenses: (C$ mm) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 F2022 F2023 F2023 F2023 F2024 F2024 F2024 F
ATS Corporation Common Shares — Q4 2024 Earnings Presentation on 6ix